Genetic markers for pancreatic cancer screening
A technology of pancreatic cancer and gene expression level, applied in the field of gene markers for pancreatic cancer examination, can solve the problems of lack of typical clinical symptoms, low early diagnosis rate, poor prognosis, etc., and achieve dynamic monitoring of easy recurrence and metastasis, high sensitivity and specificity, good user experience
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0083] The application of m1A regulated gene in the preparation of reagents or kits for pancreatic cancer diagnosis, monitoring, efficacy evaluation or metastasis and recurrence monitoring; Application in the kit;
[0084] The reagent or kit includes primers that specifically recognize ALKBH1;
[0085] High expression of ALKBH1 factor is associated with better prognosis of patients.
[0086] The expression of ALKBH1 factor was negatively correlated with the clinical grade of the subjects;
[0087] The expression of ALKBH1 factor is related to the physiological process of histone methylation.
[0088] The factor of m1A regulated gene can be applied to the diagnosis of pancreatic cancer. The ALKBH1 factor of the m1A regulated gene of the present invention is used for the diagnosis of pancreatic cancer, which can be detected earlier than clinical symptoms and signs, and provides a reference for doctors to intervene in advance.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com